90 related articles for article (PubMed ID: 8587002)
1. Comparison of cathepsin D determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay.
Shaheen RM; Miseljic S; Doering DL; Wittliff JL
J Clin Lab Anal; 1995; 9(6):351-8. PubMed ID: 8587002
[TBL] [Abstract][Full Text] [Related]
2. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
[TBL] [Abstract][Full Text] [Related]
3. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of cathepsin D assay in breast cancer tissues.
Itoh Y; Kobayashi S; Iwase H; Yamashita H; Kuzushima T; Iwata H; Yamashita T; Naitoh A; Itoh K; Masaoka A
J Surg Oncol; 1995 Dec; 60(4):221-6. PubMed ID: 8551729
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G; Titius BR
J Clin Pathol; 1996 Jan; 49(1):57-64. PubMed ID: 8666688
[TBL] [Abstract][Full Text] [Related]
6. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.
Brouillet JP; Spyratos F; Hacene K; Fauque J; Freiss G; Dupont F; Maudelonde T; Rochefort H
Eur J Cancer; 1993; 29A(9):1248-51. PubMed ID: 8343262
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay.
Eng Tan P; Benz CC; Dollbaum C; Moore DH; Edgerton SM; Zava DT; Thor AD
Ann Oncol; 1994 Apr; 5(4):329-36. PubMed ID: 8075029
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an immunoradiometric and an immunoluminometric assay for the evaluation of the tumour associated antigens CA 19-9 and CA 125.
Mader RM; Steger GG; Braun J; Rainer H
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):85-90. PubMed ID: 8003582
[TBL] [Abstract][Full Text] [Related]
9. No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays.
Barbati A; O'Brien TJ; Porpora MG; Orlacchio A; Cosmi EV
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):69-73. PubMed ID: 7493712
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri.
Sanfilippo JS; Miseljic S; Yang AR; Doering DL; Shaheen RM; Wittliff JL
Cancer; 1996 Feb; 77(4):710-6. PubMed ID: 8616763
[TBL] [Abstract][Full Text] [Related]
11. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Göhring UJ; Ingenhorst A; Crombach G; Scharl A
Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
[TBL] [Abstract][Full Text] [Related]
12. Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients.
Ravdin PM; de Moor CA; Hilsenbeck SG; Samoszuk MK; Vendely PM; Clark GM
Cancer Lett; 1997 Jun; 116(2):177-83. PubMed ID: 9215861
[TBL] [Abstract][Full Text] [Related]
13. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.
Nazeer T; Malfetano JH; Rosano TG; Ross JS
Am J Clin Pathol; 1992 Jun; 97(6):764-9. PubMed ID: 1595596
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of IMMULITE TPS: a comparison with TPS IRMA.
Einarsson R; Lei JD; Ullrich A; Van Dalen A
Anticancer Res; 1999; 19(4A):2743-7. PubMed ID: 10470233
[TBL] [Abstract][Full Text] [Related]
15. Technical and clinical comparison of two fully automated methods for the immunoassay of CA 125 in serum.
Yan G; Ju H; Liang Z; Zhang T
J Immunol Methods; 1999 May; 225(1-2):1-8. PubMed ID: 10365777
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.
Veneroni S; Daidone MG; Di Fronzo G; Cappelletti V; Amadori D; Riccobon A; Paradiso A; Correale M; Silvestrini R
Breast Cancer Res Treat; 1993; 26(1):7-13. PubMed ID: 8400325
[TBL] [Abstract][Full Text] [Related]
17. CA-125 ovarian cancer associated antigen in cancer and pregnancy: interpretation of enzyme immunoassay and immunoradiometric assay.
Touitou Y; Bogdan A; Darbois Y
Anticancer Res; 1989; 9(6):1805-7. PubMed ID: 2697189
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
19. Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.
Ferrandina G; Scambia G; Fagotti A; D'Agostino G; Benedetti Panici P; Carbone A; Mancuso S
Br J Cancer; 1998 Dec; 78(12):1645-52. PubMed ID: 9862578
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D and breast cancer.
Westley BR; May FE
Eur J Cancer; 1996 Jan; 32A(1):15-24. PubMed ID: 8695224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
